Full Text View
Tabular View
No Study Results Posted
Related Studies
STEPS Trial - Spheramine Safety and Efficacy Study
This study is ongoing, but not recruiting participants.
Study NCT00206687   Information provided by Bayer
First Received: September 13, 2005   Last Updated: September 2, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Parkinson Disease
More general conditions related to this trial
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Parkinsonian Disorders
Interventions listed in this trial
Spheramine (BAY86-5280)
Placebo
Sponsors listed in this trial
Bayer
Titan Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services